AI therapeutics company built on causal biology, today announced the acquisition of CombinAbleAI and the launch of insitro's TherML™ (Therapeutic Machine Learning) platform. The acquisition, which is ...
Partnership addresses the unmet need for remyelination therapies for multiple sclerosis and other demyelinating conditions by ...
This study introduces a dual-particle emulsion design that separates sensing and stabilization roles, enabling robust SERS detection in complex biological and environmental samples. (Nanowerk ...
Discover how Optibrium is transforming early-stage drug discovery through AI-powered software, generative chemistry, and 3D modelling. In this interview, Matt Segall, CEO at Optibrium, shares insights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback